MX2020010184A - Compuesto heterociclico. - Google Patents

Compuesto heterociclico.

Info

Publication number
MX2020010184A
MX2020010184A MX2020010184A MX2020010184A MX2020010184A MX 2020010184 A MX2020010184 A MX 2020010184A MX 2020010184 A MX2020010184 A MX 2020010184A MX 2020010184 A MX2020010184 A MX 2020010184A MX 2020010184 A MX2020010184 A MX 2020010184A
Authority
MX
Mexico
Prior art keywords
heterocyclic compound
cardiomyocyte
maturation
enhance
activity
Prior art date
Application number
MX2020010184A
Other languages
English (en)
Inventor
Yoshinori Yoshida
Kenji Miki
Akira Kaieda
Shigeru Kondo
Hiroshi Nara
Yoshinori Ikeura
Original Assignee
Orizuru Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orizuru Therapeutics Inc filed Critical Orizuru Therapeutics Inc
Publication of MX2020010184A publication Critical patent/MX2020010184A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención proporciona un compuesto heterocíclico que tiene actividad para promover la maduración de un cardiomiocito. Un compuesto representado por la fórmula (I): (ver Fórmula) en donde cada símbolo es el definido en la descripción, o una sal del mismo tiene actividad para promover la maduración de un cardiomiocito y es útil como promotor de la maduración de cardiomiocitos.
MX2020010184A 2018-03-30 2019-03-28 Compuesto heterociclico. MX2020010184A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018069872 2018-03-30
PCT/JP2019/013529 WO2019189553A1 (ja) 2018-03-30 2019-03-28 複素環化合物

Publications (1)

Publication Number Publication Date
MX2020010184A true MX2020010184A (es) 2020-10-28

Family

ID=68059192

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020010184A MX2020010184A (es) 2018-03-30 2019-03-28 Compuesto heterociclico.

Country Status (15)

Country Link
US (1) US11401264B2 (es)
EP (1) EP3778587B1 (es)
JP (1) JP7257698B2 (es)
KR (1) KR20200139210A (es)
CN (1) CN111918866B (es)
AU (1) AU2019241702B2 (es)
BR (1) BR112020019579A8 (es)
CA (1) CA3095717A1 (es)
CO (1) CO2020012101A2 (es)
ES (1) ES2966207T3 (es)
IL (1) IL277340B2 (es)
MX (1) MX2020010184A (es)
SG (1) SG11202009314XA (es)
TW (1) TWI820104B (es)
WO (1) WO2019189553A1 (es)

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602127A (en) 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5594003A (en) 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5614519A (en) 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
DE4212748A1 (de) 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
BRPI0414961A (pt) 2003-10-03 2006-11-07 Keiichi Fukuda processo de indução da diferenciação de células tronco em células do miocárdio
MXPA06011371A (es) 2004-04-10 2006-12-20 Henkel Kgaa Tubo para rizar el cabello.
AU2006262329B2 (en) 2005-06-22 2011-04-07 Asterias Biotherapeutics, Inc. Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
JP5149791B2 (ja) 2006-04-28 2013-02-20 第一三共株式会社 多能性幹細胞から心筋細胞を分化誘導する方法
US7661738B2 (en) 2006-11-28 2010-02-16 Veritainer Corporation Radiation detection unit for mounting a radiation sensor to a container crane
MX348010B (es) 2007-04-07 2017-05-23 Whitehead Inst Biomedical Res Reprogramacion de celulas somaticas.
CA2688539A1 (en) 2007-05-30 2008-12-11 The General Hospital Corporation Methods of generating pluripotent cells from somatic cells
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
WO2009118928A1 (en) 2008-03-26 2009-10-01 Kyoto University Efficient production and use of highly cardiogenic progenitors and cardiomyocytes from embryonic and induced pluripotent stem cells
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
JP5930205B2 (ja) * 2010-08-26 2016-06-08 国立大学法人京都大学 多能性幹細胞の心筋分化促進剤
JP5840855B2 (ja) 2011-03-30 2016-01-06 学校法人東京女子医科大学 胚性幹細胞から心筋シートを製造する方法
JP5920741B2 (ja) 2012-03-15 2016-05-18 ｉＨｅａｒｔ Ｊａｐａｎ株式会社 人工多能性幹細胞から心筋および血管系混合細胞群を製造する方法
EP3006559B1 (en) 2013-05-31 2019-11-06 iHeart Japan Corporation Layered cell sheet incorporating hydrogel
EP3008172B1 (en) 2013-06-11 2020-05-06 Ncardia B.V. Culture medium compositions for maturating cardiomyocytes derived from pluripotent mammalian stem cells
US10233426B2 (en) 2014-05-30 2019-03-19 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell with low-molecular compounds
WO2016076368A1 (ja) 2014-11-12 2016-05-19 テルモ株式会社 心筋細胞シート
JP2017060422A (ja) * 2015-09-24 2017-03-30 国立大学法人 東京大学 成熟した心筋細胞を分化誘導させる方法
JP6702134B2 (ja) 2016-10-27 2020-05-27 トヨタ自動車株式会社 電動車両

Also Published As

Publication number Publication date
KR20200139210A (ko) 2020-12-11
RU2020135574A (ru) 2022-05-04
TWI820104B (zh) 2023-11-01
ES2966207T3 (es) 2024-04-18
AU2019241702B2 (en) 2023-07-27
EP3778587B1 (en) 2023-10-04
WO2019189553A1 (ja) 2019-10-03
IL277340A (en) 2020-10-29
CN111918866B (zh) 2023-07-04
TW201942354A (zh) 2019-11-01
BR112020019579A2 (pt) 2021-01-12
IL277340B2 (en) 2024-07-01
JP7257698B2 (ja) 2023-04-14
AU2019241702A1 (en) 2020-10-08
CO2020012101A2 (es) 2020-12-10
EP3778587A1 (en) 2021-02-17
CA3095717A1 (en) 2019-10-03
CN111918866A (zh) 2020-11-10
US11401264B2 (en) 2022-08-02
SG11202009314XA (en) 2020-10-29
JPWO2019189553A1 (ja) 2021-03-25
EP3778587C0 (en) 2023-10-04
IL277340B1 (en) 2024-03-01
EP3778587A4 (en) 2021-10-06
US20210024512A1 (en) 2021-01-28
BR112020019579A8 (pt) 2022-10-18

Similar Documents

Publication Publication Date Title
EA201791584A1 (ru) Агрохимическая композиция
PH12017502171B1 (en) PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
PH12017502407A1 (en) Fused pyrimidine compound or salt thereof
SG11201901061QA (en) Heterocyclic compound
PH12016500225B1 (en) Novel quinoline-substituted compound
MY175448A (en) Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifna responses
PH12014501719A1 (en) Pyridone derivatives
MA39001A1 (fr) Composés pyridyle substitués par alkyl-amide, utiles comme modulateurs d'il-12, il-23 et/ou de réponses à l'ifn?
MY194307A (en) Pyridone derivative having tetrahydropyranylmethyl group
PH12018502012A1 (en) Griseofulvin compound
JO3318B1 (ar) مثبطات bace
MX2018011716A (es) Compuesto de piridazinona o su sal, y herbicida que lo contiene.
PH12016502130B1 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
MX2021015514A (es) Compuesto heterociclico.
PH12018501642B1 (en) Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
EA201790016A1 (ru) АНАЛОГ ПИРИДИНО[1,2-a]ПИРИМИДОНА, ПРИМЕНЯЕМЫЙ В КАЧЕСТВЕ ИНГИБИТОРА PI3K
SG11201810725WA (en) Novel β-lactamase inhibitors
MX2019013979A (es) Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
WO2018194181A8 (en) HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF ACETYLCHOLINE RECEPTORS
AU2015309863A8 (en) Azaindole derivative having AMPK-activating effect
PH12019501171A1 (en) Pyrido [3, 4-d] pyrimidine derivative and pharmaceutically acceptable salt thereof
TN2021000025A1 (en) Novel heterocyclic amine derivative and pharmaceutical composition comprising same
ZA202101487B (en) Novel compounds
MX2018000459A (es) Metodo para la fabricacion de compuestos heterociclicos que contienen nitrogeno y compuestos intermediarios de los mismos.
MY185558A (en) Pyrido-oxazinone derivatives as tnap inhibitors

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ORIZURU THERAPEUTICS, INC.